Resources » Learning Center » Webinars
Resources
contact us
Time:
All Today Tomorrow This Week This Month
Categories:
All Synthetic Biology Gene CRISPR Peptide Antibody Protein Biologics NGS Tools Catalog Product IVT RNA
Applications:
All Synthetic Biology Cancer Immunotherapy CRISPR Genome Editing Infectious Disease Plant Biology Drug Discovery Vaccine Development Stem Cell Tools and Tutorials Next-Generation Sequencing Protein Purification Protein Analysis mRNA Therapeutics Protein Replacement Cancer Vaccine Gene Editing
Type:
All Upcoming Recorded
12 Results

Bispecific Single-Domain Antibody fused to Monoclonal Antibody (SMAB): The Natural Form

Within the past 3 years alone, the FDA has approved 20 novel antibody therapeutics for oncological treatment, with over 300 therapeutic antibodies currently in oncology based clinical trials. However, despite this exponential growth

10-17-2018 Li Chen, Ph.D., Principal Project Manager

Learn More

Bispecific Antibodies: The Next Generation of Antibody Therapeutics

Within the past 3 years alone, the FDA has approved 20 novel antibody therapeutics for oncological treatment

07-11-2018 Dr. Liusong Yin

Learn More

Antibody drug development: challenges & solutions

Are you working on antibody drug development with a challenging target, such as membrane proteins (e.g. GPCRs and ion channels), immune checkpoint proteins and cytokines etc.?

08-16-2016 Liusong Yin, Ph.D.

Learn More

Anti-idiotype Antibody Generation and Application in Antibody Drug Discovery

Are you developing antibody drugs? Have you considered generating anti-idiotype antibodies (anti-IDs)? Anti-IDs recognize the region unique to your antibody drug, the complementarity determining region (CDR)

04-21-2016 Liusong Yin, Ph.D.

Learn More

Anti-idiotype antibody generation and application in antibody drug discovery

Are you developing antibody drugs? Have you considered generating anti-idiotype antibodies (anti-IDs)?

11-27-2015 Michelle Parker, Ph.D.

Learn More

Biologics Drug Discovery: Steps to Achieving an Antibody Drug Candidate

In the past decade, drug discovery has focused on developing biologics. In particular, antibody therapeutics have been proven to be clinically effective for disease areas such as oncology and immunology.

07-28-2015 Frank Fan, M.D.Ph.D.

Learn More

< 1 2 > Total Pages 2